Cargando…
Therapy with the Combination of Tolvaptan and Furosemide for Refractory Edema in Nephrotic Syndrome
Autores principales: | Meena, Jitendra, Sinha, Aditi, Hari, Pankaj, Bagga, Arvind |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977386/ https://www.ncbi.nlm.nih.gov/pubmed/32015605 http://dx.doi.org/10.4103/ijn.IJN_358_18 |
Ejemplares similares
-
SARS-CoV-2 infection in children with nephrotic syndrome
por: Krishnasamy, Sudarsan, et al.
Publicado: (2022) -
Albumin and Furosemide Combination for Management of Edema in Nephrotic Syndrome: A Review of Clinical Studies
por: Duffy, Margaret, et al.
Publicado: (2015) -
Prevalence of Bladder and Bowel Dysfunction in Toilet-Trained Children With Urinary Tract Infection and/or Primary Vesicoureteral Reflux: A Systematic Review and Meta-Analysis
por: Meena, Jitendra, et al.
Publicado: (2020) -
Efficacy of rituximab versus tacrolimus in difficult-to-treat steroid-sensitive nephrotic syndrome: an open-label pilot randomized controlled trial
por: Mathew, Georgie, et al.
Publicado: (2022) -
Re-response to tolvaptan after furosemide dose reduction in a patient with refractory ascites
por: Goto, Atsushi, et al.
Publicado: (2014)